skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Using Genome-Editing Technologies to Mitigate Antimicrobial Resistance [CRISPR-Based Antibacterials: Transforming Bacterial Defense into Offense]

Journal Article · · Trends in Biotechnology

The development of antimicrobial-resistant (AMR) bacteria poses a serious worldwide health concern. CRISPR-based antibacterials, however, are a novel and adaptable method for building an arsenal of antibacterials potentially capable of targeting any pathogenic bacteria.

Research Organization:
Sandia National Lab. (SNL-NM), Albuquerque, NM (United States)
Sponsoring Organization:
USDOE National Nuclear Security Administration (NNSA); USDOD Defense Threat Reduction Agency (DTRA)
DOE Contract Number:
AC04-94AL85000; NA0003525
OSTI ID:
1429637
Report Number(s):
SAND-2017-10459J; 657331
Journal Information:
Trends in Biotechnology, Vol. 36, Issue 2; Related Information: Early version; ISSN 0167-7799
Publisher:
Elsevier
Country of Publication:
United States
Language:
English

References (13)

Clinical development success rates for investigational drugs journal January 2014
Next-generation precision antimicrobials: towards personalized treatment of infectious diseases journal June 2017
Advances in Industrial Biotechnology Using CRISPR-Cas Systems journal February 2018
CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes journal March 2007
Consequences of Cas9 cleavage in the chromosome of Escherichia coli journal April 2016
CRISPR technologies for bacterial systems: Current achievements and future directions journal November 2016
Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases journal September 2014
Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials journal October 2014
Programmable Removal of Bacterial Strains by Use of Genome-Targeting CRISPR-Cas Systems journal January 2014
Engineering Modular Viral Scaffolds for Targeted Bacterial Population Editing journal September 2015
Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria journal May 2015
CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery journal June 2017
Confinement-induced quorum sensing of individual Staphylococcus aureus bacteria journal November 2009

Cited By (11)

Future Antibacterial Strategies: From Basic Concepts to Clinical Challenges journal March 2019
Gene editing in dermatology: Harnessing CRISPR for the treatment of cutaneous disease journal January 2020
Gene Editing and Systems Biology Tools for Pesticide Bioremediation: A Review journal February 2019
Insights Into Non-coding RNAs as Novel Antimicrobial Drugs journal February 2019
Application of new biotechnologies for improvements in swine nutrition and pork production journal April 2019
High Throughput Manufacturing of Bacteriophages Using Continuous Stirred Tank Bioreactors Connected in Series to Ensure Optimum Host Bacteria Physiology for Phage Production journal October 2018
CRISPR-cas system: biological function in microbes and its use to treat antimicrobial resistant pathogens journal July 2019
Antimicrobial peptides from fish: beyond the fight against pathogens journal November 2018
Interference With Quorum-Sensing Signal Biosynthesis as a Promising Therapeutic Strategy Against Multidrug-Resistant Pathogens journal February 2019
Gene editing in dermatology: Harnessing CRISPR for the treatment of cutaneous disease journal January 2020
Endogenous CRISPR-Cas System-Based Genome Editing and Antimicrobials: Review and Prospects journal October 2019

Similar Records

CRISPR-Based Antibacterials: Transforming Bacterial Defense into Offense
Journal Article · Fri Nov 17 00:00:00 EST 2017 · Trends in Biotechnology · OSTI ID:1429637

Predicting antimicrobial susceptibility from the bacterial genome: A new paradigm for one health resistance monitoring
Journal Article · Sat Oct 03 00:00:00 EDT 2020 · Journal of Veterinary Pharmacology and Therapeutics · OSTI ID:1429637

Reversal of carbapenem-resistance in Shewanella algae by CRISPR/Cas9 genome editing
Journal Article · Thu Jan 31 00:00:00 EST 2019 · Journal of Advanced Research · OSTI ID:1429637